An attempt to prevent senescence: a mitochondrial approach - PubMed (original) (raw)
Review
. 2009 May;1787(5):437-61.
doi: 10.1016/j.bbabio.2008.12.008. Epub 2008 Dec 29.
Vladimir N Anisimov, Yuri N Antonenko, Lora E Bakeeva, Boris V Chernyak, Valery P Erichev, Oleg F Filenko, Natalya I Kalinina, Valery I Kapelko, Natalya G Kolosova, Boris P Kopnin, Galina A Korshunova, Mikhail R Lichinitser, Lidia A Obukhova, Elena G Pasyukova, Oleg I Pisarenko, Vitaly A Roginsky, Enno K Ruuge, Ivan I Senin, Inna I Severina, Maxim V Skulachev, Irina M Spivak, Vadim N Tashlitsky, Vsevolod A Tkachuk, Mikhail Yu Vyssokikh, Lev S Yaguzhinsky, Dmitry B Zorov
Affiliations
- PMID: 19159610
- DOI: 10.1016/j.bbabio.2008.12.008
Free article
Review
An attempt to prevent senescence: a mitochondrial approach
Vladimir P Skulachev et al. Biochim Biophys Acta. 2009 May.
Free article
Abstract
Antioxidants specifically addressed to mitochondria have been studied to determine if they can decelerate senescence of organisms. For this purpose, a project has been established with participation of several research groups from Russia and some other countries. This paper summarizes the first results of the project. A new type of compounds (SkQs) comprising plastoquinone (an antioxidant moiety), a penetrating cation, and a decane or pentane linker has been synthesized. Using planar bilayer phospholipid membrane (BLM), we selected SkQ derivatives with the highest permeability, namely plastoquinonyl-decyl-triphenylphosphonium (SkQ1), plastoquinonyl-decyl-rhodamine 19 (SkQR1), and methylplastoquinonyldecyltriphenylphosphonium (SkQ3). Anti- and prooxidant properties of these substances and also of ubiquinonyl-decyl-triphenylphosphonium (MitoQ) were tested in aqueous solution, detergent micelles, liposomes, BLM, isolated mitochondria, and cell cultures. In mitochondria, micromolar cationic quinone derivatives were found to be prooxidants, but at lower (sub-micromolar) concentrations they displayed antioxidant activity that decreases in the series SkQ1=SkQR1>SkQ3>MitoQ. SkQ1 was reduced by mitochondrial respiratory chain, i.e. it is a rechargeable antioxidant. Nanomolar SkQ1 specifically prevented oxidation of mitochondrial cardiolipin. In cell cultures, SkQR1, a fluorescent SkQ derivative, stained only one type of organelles, namely mitochondria. Extremely low concentrations of SkQ1 or SkQR1 arrested H(2)O(2)-induced apoptosis in human fibroblasts and HeLa cells. Higher concentrations of SkQ are required to block necrosis initiated by reactive oxygen species (ROS). In the fungus Podospora anserina, the crustacean Ceriodaphnia affinis, Drosophila, and mice, SkQ1 prolonged lifespan, being especially effective at early and middle stages of aging. In mammals, the effect of SkQs on aging was accompanied by inhibition of development of such age-related diseases and traits as cataract, retinopathy, glaucoma, balding, canities, osteoporosis, involution of the thymus, hypothermia, torpor, peroxidation of lipids and proteins, etc. SkQ1 manifested a strong therapeutic action on some already pronounced retinopathies, in particular, congenital retinal dysplasia. With drops containing 250 nM SkQ1, vision was restored to 67 of 89 animals (dogs, cats, and horses) that became blind because of a retinopathy. Instillation of SkQ1-containing drops prevented the loss of sight in rabbits with experimental uveitis and restored vision to animals that had already become blind. A favorable effect of the same drops was also achieved in experimental glaucoma in rabbits. Moreover, the SkQ1 pretreatment of rats significantly decreased the H(2)O(2) or ischemia-induced arrhythmia of the isolated heart. SkQs strongly reduced the damaged area in myocardial infarction or stroke and prevented the death of animals from kidney ischemia. In p53(-/-) mice, 5 nmol/kgxday SkQ1 decreased the ROS level in the spleen and inhibited appearance of lymphomas to the same degree as million-fold higher concentration of conventional antioxidant NAC. Thus, SkQs look promising as potential tools for treatment of senescence and age-related diseases.
Similar articles
- A biochemical approach to the problem of aging: "megaproject" on membrane-penetrating ions. The first results and prospects.
Skulachev VP. Skulachev VP. Biochemistry (Mosc). 2007 Dec;72(12):1385-96. doi: 10.1134/s0006297907120139. Biochemistry (Mosc). 2007. PMID: 18205623 Review. - Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies.
Antonenko YN, Avetisyan AV, Bakeeva LE, Chernyak BV, Chertkov VA, Domnina LV, Ivanova OY, Izyumov DS, Khailova LS, Klishin SS, Korshunova GA, Lyamzaev KG, Muntyan MS, Nepryakhina OK, Pashkovskaya AA, Pletjushkina OY, Pustovidko AV, Roginsky VA, Rokitskaya TI, Ruuge EK, Saprunova VB, Severina II, Simonyan RA, Skulachev IV, Skulachev MV, Sumbatyan NV, Sviryaeva IV, Tashlitsky VN, Vassiliev JM, Vyssokikh MY, Yaguzhinsky LS, Zamyatnin AA Jr, Skulachev VP. Antonenko YN, et al. Biochemistry (Mosc). 2008 Dec;73(12):1273-87. doi: 10.1134/s0006297908120018. Biochemistry (Mosc). 2008. PMID: 19120014 - Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 4. Age-related eye disease. SkQ1 returns vision to blind animals.
Neroev VV, Archipova MM, Bakeeva LE, Fursova AZh, Grigorian EN, Grishanova AY, Iomdina EN, Ivashchenko ZhN, Katargina LA, Khoroshilova-Maslova IP, Kilina OV, Kolosova NG, Kopenkin EP, Korshunov SS, Kovaleva NA, Novikova YP, Philippov PP, Pilipenko DI, Robustova OV, Saprunova VB, Senin II, Skulachev MV, Sotnikova LF, Stefanova NA, Tikhomirova NK, Tsapenko IV, Shchipanova AI, Zinovkin RA, Skulachev VP. Neroev VV, et al. Biochemistry (Mosc). 2008 Dec;73(12):1317-28. doi: 10.1134/s0006297908120043. Biochemistry (Mosc). 2008. PMID: 19120017 - Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke).
Bakeeva LE, Barskov IV, Egorov MV, Isaev NK, Kapelko VI, Kazachenko AV, Kirpatovsky VI, Kozlovsky SV, Lakomkin VL, Levina SB, Pisarenko OI, Plotnikov EY, Saprunova VB, Serebryakova LI, Skulachev MV, Stelmashook EV, Studneva IM, Tskitishvili OV, Vasilyeva AK, Victorov IV, Zorov DB, Skulachev VP. Bakeeva LE, et al. Biochemistry (Mosc). 2008 Dec;73(12):1288-99. doi: 10.1134/s000629790812002x. Biochemistry (Mosc). 2008. PMID: 19120015 - Mitochondrial-targeted plastoquinone derivatives. Effect on senescence and acute age-related pathologies.
Skulachev MV, Antonenko YN, Anisimov VN, Chernyak BV, Cherepanov DA, Chistyakov VA, Egorov MV, Kolosova NG, Korshunova GA, Lyamzaev KG, Plotnikov EY, Roginsky VA, Savchenko AY, Severina II, Severin FF, Shkurat TP, Tashlitsky VN, Shidlovsky KM, Vyssokikh MY, Zamyatnin AA Jr, Zorov DB, Skulachev VP. Skulachev MV, et al. Curr Drug Targets. 2011 Jun;12(6):800-26. doi: 10.2174/138945011795528859. Curr Drug Targets. 2011. PMID: 21269268 Review.
Cited by
- Don´t give up on mitochondria as a target for the treatment of diabetes and its complications.
Cortés-Rojo C, Vargas-Vargas MA. Cortés-Rojo C, et al. World J Diabetes. 2024 Oct 15;15(10):2015-2021. doi: 10.4239/wjd.v15.i10.2015. World J Diabetes. 2024. PMID: 39493563 Free PMC article. - Plastoquinone-Derivative SkQ1 Improved the Biliary Intraepithelial Neoplasia during Liver Fluke Infection.
Zaparina O, Kovner A, Petrova V, Kolosova N, Mordvinov V, Pakharukova M. Zaparina O, et al. Curr Issues Mol Biol. 2024 Feb 17;46(2):1593-1606. doi: 10.3390/cimb46020103. Curr Issues Mol Biol. 2024. PMID: 38392221 Free PMC article. - Insights on Targeting Small Molecules to the Mitochondrial Matrix and the Preparation of MitoB and MitoP as Exomarkers of Mitochondrial Hydrogen Peroxide.
Cairns AG, McQuaker SJ, Murphy MP, Hartley RC. Cairns AG, et al. Methods Mol Biol. 2021;2275:87-117. doi: 10.1007/978-1-0716-1262-0_6. Methods Mol Biol. 2021. PMID: 34118033 - Mitochondrial targeting as a novel therapy for stroke.
Russo E, Nguyen H, Lippert T, Tuazon J, Borlongan CV, Napoli E. Russo E, et al. Brain Circ. 2018 Jul-Sep;4(3):84-94. doi: 10.4103/bc.bc_14_18. Epub 2018 Oct 9. Brain Circ. 2018. PMID: 30450413 Free PMC article. Review. - Chemical genetic screen identifies lithocholic acid as an anti-aging compound that extends yeast chronological life span in a TOR-independent manner, by modulating housekeeping longevity assurance processes.
Goldberg AA, Richard VR, Kyryakov P, Bourque SD, Beach A, Burstein MT, Glebov A, Koupaki O, Boukh-Viner T, Gregg C, Juneau M, English AM, Thomas DY, Titorenko VI. Goldberg AA, et al. Aging (Albany NY). 2010 Jul;2(7):393-414. doi: 10.18632/aging.100168. Aging (Albany NY). 2010. PMID: 20622262 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous